| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972008 | The Journal of Heart and Lung Transplantation | 2009 | 7 Pages |
Abstract
In end-stage congestive cardiac failure, intravenous milrinone and sildenafil both cause similar reductions in systemic and pulmonary vascular resistance; however, milrinone has more cardiac selective effects on left ventricular filling and heart rate. Both agents appear to have a suitable hemodynamic profile for testing of reversibility of secondary pulmonary hypertension in congestive cardiac failure. Larger studies are needed to confirm these results.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Phil MRCS, Gareth FRCP, John H. FRCS, Guy A. MD, FRCPI,